Anthony L. Zietman, MD, MBBS

Jenot W. and William U. Shipley Professor of Radiation Oncology, Department of Radiation Oncology, Harvard Medical School

Director, Radiation Oncology Residency Program, Massachusetts General Hospital

Contact Info

Anthony Zietman
Massachusetts General Hospital
100 Blossom Street
Boston, MA, 02114
Mailstop: Cox 3
Phone: 617-724-1160
Fax: 617-726-3603
azietman@partners.org

Assistant

Phyllis Neely
Administrative Specialist
Prostate Cancer Program
Massachusetts General Hospital
pneely@partners.org

DF/HCC Program Affiliation

Prostate Cancer

Research Abstract

In prostate cancer I am exploring the therapeutic gains possible from radiation dose escalation using conformal radiation therapy with the proton beam. Combinations of external radiation and brachytherapy are also under investigation. A large data-base of over 3000 patients has been developed and is being used to investigate prognostic factors in prostate cancer and to evaluate treatment outcomes. In bladder cancer, together with Dr W.U. Shipley, we have an active program exploring alternatives to cystectomy for muscle-invading tumors.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Anthony L. Zietman, MD, MBBS Jenot W. and William U. Shipley Professor of Radiation Oncology, Department of Radiation Oncology, Harvard Medical School Director, Radiation Oncology Residency Program, Massachusetts General Hospital Contact Info Anthony Zietman Massachusetts General Hospital 100 Blossom Street Boston, MA, 02114 Mailstop: Cox 3 Phone: 617-724-1160 Fax: 617-726-3603 azietman@partners.org Assistant Phyllis Neely Administrative Specialist Prostate Cancer Program Massachusetts General Hospital pneely@partners.org DF/HCC Program Affiliation Prostate Cancer Research Abstract In prostate cancer I am exploring the therapeutic gains possible from radiation dose escalation using conformal radiation therapy with the proton beam. Combinations of external radiation and brachytherapy are also under investigation. A large data-base of over 3000 patients has been developed and is being used to investigate prognostic factors in prostate cancer and to evaluate treatment outcomes. In bladder cancer, together with Dr W.U. Shipley, we have an active program exploring alternatives to cystectomy for muscle-invading tumors. Publications View All Publications
Site Map Site Feedback Web Privacy Policy